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1999; Hagerman and Hagerman, 2002). Transgenic mouse and fly 
models, lack FMRP, and like affected humans, show an equivalent 
behavioral phenotype (Bakker, 1994; Musumeci et al., 2000; Nielsen 
et al., 2002; Spencer et al., 2005; Brennan et al., 2006).
Molecular pathobiology of fXS
Fragile X mental retardation protein normally functions as a an 
inhibitory  regulator  of  translation  of  metabotropic  glutamate 
receptor 5 (mGluR5) (Laggerbauer et al., 2001; Li et al., 2001; Zhang 
et al., 2001; Bear et al., 2004). Thus the loss of FMRP results in exces-
sive translation of mGluR5. mGluR5 plays an integral role in the 
establishment of new synaptic connections (Le Be and Markram, 
2006) and thus is critical to stabilizing long-term depression (LTD) 
and inducing long-term potentiation (LTP) (Simonyi et al., 2005). 
The excessive mGluR5 activity caused by the lack of FMRP is appar-
ent neuroanatomically with an increased density of long, thin aber-
rantly shaped dendritic spines in post mortem studies (Irwin et al., 
introduction
Fragile X syndrome (FXS), an X-linked disorder affecting 1 in 4000 
males and at least 1 in 8000 females (O’Donnell and Warren, 2002), 
is the most common heritable cause of intellectual disability. Thirty 
percent of children with FXS are diagnosed with autism and 2–5% 
of autistic children have FXS (Kaufmann et al., 2004; Hagerman 
et al., 2005). FXS arises from a mutation in the X-chromosome 
gene FMR1, due to transcriptional silencing resulting from hyper-
methylation of an expansion of the CGG trinucleotide (Pfeiffer 
and Huber, 2009). The silencing of FMR1 transcription prevents or 
reduces translation of its protein product, fragile X mental retarda-
tion protein (FMRP) (Tassone et al., 1999). The cognitive behavio-
ral phenotype of FXS includes general cognitive impairment (with 
moderate deficits in males and variable deficits in females that can 
range from as severely affected as males to asymptomatic), hypera-
rousal, hypersensitivity to sensory stimuli, anxiety, epilepsy, ADHD, 
and as mentioned above, characteristics of autism (Miller et al., 
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Fragile X Syndrome (FXS) is the most common heritable cause of intellectual disability. In 
vitro electrophysiologic data from mouse models of FXS suggest that loss of fragile X mental 
retardation protein affects intracortical excitability and synaptic plasticity. Specifically, the 
cortex appears hyperexcitable, and use-dependent long-term potentiation (LTP) and long-term 
depression (LTD) of synaptic strength are abnormal. Though animal models provide important 
information, FXS and other neurodevelopmental disorders are human diseases and as such 
translational research to evaluate cortical excitability and plasticity must be applied in the 
human. Transcranial magnetic stimulation paradigms have recently been developed to non-
invasively investigate cortical excitability using paired pulse stimulation, as well as LTP- and 
LTD-like synaptic plasticity in response to theta burst stimulation (TBS) in vivo in the human. 
TBS applied on consecutive days can be used to measure metaplasticity (the ability of the 
synapse to undergo a second plastic change following a recent induction of plasticity). The 
current study investigated intracortical inhibition, plasticity and metaplasticity in full mutation 
females with FXS, participants with autism spectrum disorders (ASD), and neurotypical controls. 
Results suggest that intracortical inhibition is normal in participants with FXS, while plasticity 
and metaplasticity appear abnormal. ASD participants showed abnormalities in plasticity and 
metaplasticity, as well as heterogeneity in intracortical inhibition. Our findings highlight the 
utility of non-invasive neurophysiological measures to translate insights from animal models 
to humans with neurodevelopmental disorders, and thus provide direct confirmation of cortical 
dysfunction in patients with FXS and ASD.
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2001) and animal models of fragile X (Irwin et al., 2002). This 
dysregulation caused by mGluR5 over activity is thought to lead to 
a number of characteristic FXS neurological and behavioral phe-
notypes, including epilepsy, cognitive impairment, developmental 
delay, and loss of motor coordination. Thus, if the mGluR receptor 
is allowed to activate without inhibition from FMRP, one would 
expect to see abnormalities in both cortical plasticity and excit-
ability (see Bear et al., 2004 for a review). Indeed, in vitro data 
from Fmr1 knockout mouse FXS models show exaggerated LTD of 
excitatory synaptic strength with low frequency electrical stimula-
tion (Huber et al., 2002; Koekkoek et al., 2005; Hou et al., 2006) and 
impaired LTP of excitatory synapses with high frequency electrical 
stimulation (Li et al., 2002; Zhao et al., 2005; Desai et al., 2006; 
Meredith et al., 2007; Wilson and Cox, 2007). The mouse model 
data also show decreased expression of the GABAA receptor in the 
cortex, hippocampus, diencephalon, and brainstem (see D’Hulst 
and Kooy, 2007) leading to an overall hyperexcitable brain due to 
lack of GABAA mediated intracortical inhibition.
Studying cortical eXcitability and plaSticity  
in vivo in the huMan
Though animal models provide an invaluable resource for under-
standing the neurophysiology of disease, it is often difficult to trans-
late these insights into studies that can be done in patients with the 
disorders. In the human, the neurophysiological substrate may be 
the same as or different from the animal model, thus non-invasive 
neurophysiological studies using stimulation techniques in humans 
that are analogous to those used in basic physiologic experiments 
provide a means to validate findings reported in animal models. Here 
we propose that non-invasive methods can be used to evaluate cortical 
excitability and plasticity in vivo in patients with neurodevelopmental 
disorders. In doing so, we are able to show in patients with FXS that 
abnormalities in cortical plasticity exist, which are analogous to those 
reported in mouse models. Specifically, we used transcranial magnetic 
stimulation (TMS) to measure cortical excitability and plasticity in 
patients with FXS, individuals with autism spectrum disorder (ASD) 
without FXS, and healthy, neurotypical controls.
During TMS, small intracranial electrical currents are generated 
by a powerful fluctuating extracranial magnetic field. Measures of 
cortico-spinal excitability can then be obtained both at baseline 
and following a train of stimulation by peripherally measuring the 
motor-evoked potential in the muscle corresponding to the region 
of motor cortex that is stimulated. Specific TMS protocols have 
been introduced in an effort to investigate cortical excitability and 
plasticity mechanisms in the human brain. These protocols include 
adaptations of paired pulse stimulation (Kujirai et al., 1993) and 
theta burst stimulation (TBS) (Huang et al., 2005). Paired pulse 
stimulation can be delivered using different inter-pulse intervals to 
evaluate excitatory and inhibitory mechanisms and thus provide 
insights into cortical excitation/inhibition balance (E/I balance) 
(Kobayashi and Pascual-Leone, 2003). TBS can assess LTP-like and 
LTD-like plasticity by introducing a train of high frequency stimu-
lation and then evaluating the cortical or cortical-spinal response 
to single-pulse TMS for a period of time following the plasticity-
inducing train. Finally, we can evaluate metaplasticity by investigat-
ing the effect of a single session of TBS on a subsequent session of 
TBS carried out 24 h later (see Figure 1).
In the conventional paired pulse paradigm, two consecutive 
magnetic stimuli, a conditioning stimulus (CS) and a test stimulus 
(TS), are delivered through a TMS-coil over the motor cortex (Claus 
et al., 1992; Kujirai et al., 1993; Ziemann, 1999). An inter-pulse 
interval of 1–6 ms is thought to evaluate short interval intracorti-
cal inhibition (SICI). It is hypothesized that SICI is mediated by 
GABAergic intracortical inhibitory neurons and specifically by the 
GABAA receptor (Kujirai et al., 1993). Two suprathreshold pulses 
delivered at an inter-pulse interval of 50–200 ms is thought to 
evaluate long interval intracortical inhibition (LICI) and thought 
to reflect long-lasting cortical inhibition mediated by the GABAB 
receptor (Valls-Sole et al., 1992).
While paired pulse TMS is capable of evaluating intracortical 
inhibition, TBS provides a non-invasive index of LTP-like and 
LTD-like cortical plasticity in the human brain (Huang et al., 
2005). Theta burst TMS protocols lead to changes in cortical 
activity that last well beyond the duration of the TMS application, 
show a time course consistent with that found with LTP, and LTD 
in slice preparations, and are also modulated by glutamatergic 
and GABAergic mediators (Huang et al., 2007; Stagg et al., 2009). 
The propensity of a given synapse to exhibit LTP or LTD can be 
altered based on its recent history. This “plasticity of plasticity” 
is referred to as metaplasticity and entails a change in the state 
of the synapse that alters its ability to make subsequent plastic 
changes. Metaplasticity involves many of the same mechanisms 
as conventional LTP and LTD (including activation of metabo-
tropic glutamate receptors and changes in intrinsic excitability of 
the post-synaptic neuron) and is thought to serve a homeostatic 
function to ensure that plasticity is kept within a normal working 
range (Abraham, 2008).
evidence for abnorMal plaSticity in aSd
In a recent study, we used TBS to investigate cortical plasticity 
of the motor system in 25 individuals with ASDs. Results sug-
gest that the change in cortical excitability following TBS lasts 
approximately 200–300% longer in the ASD group, compared with 
a matched control group. While the typical response to TBS lasts 
approximately 25–30 min, the average time to return to baseline 
in the ASD group was 80–90 min. Importantly, this abnormal 
prolongation of the plastic response to TBS is induced by both, 
continuous and intermittent TBS (cTBS and iTBS) thus suggest-
ing aberrant plasticity in both, LTD- and LTP-like mechanisms. 
Furthermore, the same hyperplastic state is present in all 25 indi-
viduals with ASD, suggesting a consistent dysfunction despite 
likely genetic variability. These findings provide novel insights 
into the pathophysiology of ASD, consistent with recent results 
of animal models (Markram et al., 2007) that might become a 
biomarker for ASD, and ultimately offer a target for novel thera-
peutic interventions.
the current Study
The current study aimed to evaluate intracortical inhibition, plas-
ticity, and metaplasticity in individuals with FXS, and individu-
als with ASD. We assessed intracortical inhibition through paired 
pulse stimulation, cortical plasticity through response to TBS, and 
metaplasticity through response to TBS given 24 h after an ini-
tial TBS session, in individuals with FXS, ASD, and neurotypical Frontiers in Synaptic Neuroscience  www.frontiersin.org  June 2010  | Volume 2  | Article 26  |  3
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in both sessions while one only participated in the paired pulse 
session, and two neurotypical controls participated in both ses-
sions while the other three participated in only the paired pulse 
session. All participants were right handed as assessed by revised 
Edinburgh  Handedness  Inventory  (Oldfield,  1971;  Schachter, 
1994). Participants were recruited through the National Fragile 
X Society, FRAXA, local community advertisement, and local 
Asperger’s Associations and clinics. Both participants with FXS 
had a diagnosis with molecular confirmation of full mutation 
status, and all participants in the ASD group met DSM-IV-TR 
criteria for Asperger’s syndrome. All participants in all groups 
scored within the normal range on the Weschler Abbreviated Scale 
of Intelligence. The participants in the typically developing group 
had no neurological or psychological disorder.
All participants underwent a neurological exam to assess strength, 
tone, fine, and gross motor skills, involuntary movements, and gait, 
to ensure normal motor functioning. All participants signed an 
informed consent form. The project was reviewed and approved 
by the local institutional review board.
  controls. Based on data from animal models of FXS, and on prior 
data in our laboratory, we hypothesized that intracortical inhibi-
tion, plasticity, and metaplasticity might be abnormal in individuals 
with FXS and ASD, as compared to typically developing control 
participants. In addition to new insights into the pathophysiology 
of FXS and ASD in humans, our results demonstrate the utility 
of non-invasive measures to characterize E/I balance and cortical 
plasticity in translational neuroscience to non-invasively extend 




We studied two full mutation females with FXS (age 16 and 33), 
five individuals with ASD (three males and two females; ages 26, 
35, 44, 45, 54) and five neurotypical controls (two males and three 
females; ages 22, 27, 41, 49, and 54). The two individuals with FXS 
participated in both the paired pulse and plasticity/metaplastic-
ity sessions, four of the five individuals with ASD participated 
Figure 1 | Schematic summary of applied methodology. Cortico-spinal 
excitability can be evaluated by comparing motor-evoked potentials (MEPs) 
recorded from the peripheral muscle in response to a single pulse to the primary 
motor cortex. These responses can then be obtained both at baseline and 
following continuous or intermittent theta burst stimulation (TBS), producing a 
measure of local cortical plasticity. TBS involves applying bursts of high 
frequency magnetic stimulation (three pulses at 50 Hz) repeated at intervals of 
200 ms. After TBS is applied to the motor cortex in an intermittent fashion (iTBS), 
single pulse TMS-induced MEPs show increased amplitude for a period of 
20–30 min, whereas continuous TBS (cTBS) leads to a suppression of the 
TMS-induced MEPs for approximately the same amount of time (Huang et al., 
2005). Post-TBS enhancement (following iTBS) or suppression (after cTBS) of 
the cortical activity is considered an index of LTP and LTD-like induction of 
plasticity in the targeted brain area. Paired pulses to the primary motor cortex 
with either 3 or 100 ms interstimulus interval can be applied during a separate 
session to evaluate intracortical inhibition.Frontiers in Synaptic Neuroscience  www.frontiersin.org  June 2010  | Volume 2  | Article 26  |  4
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eXperiMental deSign
Participants were seated in a comfortable chair for the duration of 
the study. Paired pulse and TBS sessions were conducted on sepa-
rate days with a minimum of 1 week between these sessions. TBS 
sessions were conducted on two consecutive days (see Figure 2) in 
order to simultaneously evaluate plasticity and metaplasticity proc-
esses. Resulting in three experimental sessions (one paired pulse 
session and two TBS sessions).
intracortical inhibition
Paired pulse paradigms were delivered at two inter-pulse intervals: 
3 ms to elicit SICI and 100 ms to elicit LICI. Each pair was deliv-
ered at a rate of approximately 0.1 Hz (a random jitter of ±1 s was 
introduced to avoid any train effects). For SICI the first pulse was 
delivered at 80% of RMT (subthreshold) while the second pulse 
was delivered at 120% of RMT (suprathreshold). LICI was evalu-
ated using two pulses delivered at 120% of RMT. For each subject 
an average SICI and LICI response was determined by calculating 
the mean of 20 MEPs each. These paired stimulations were then 
compared to the mean of 20 MEPs in response to single pulses at 
120% RMT, to create a ratio indicating the degree of suppression 
in the MEP during SICI and LICI as compared to single pulses. 
The order of SICI, LICI, and single pulses was counterbalanced 
between subjects to control for order effects.
Cortical plasticity and metaplasticity
Theta burst stimulation was applied using the parameters intro-
duced by Huang et al. (2005) (three pulses at 50 Hz at an intensity 
of 80% of AMT at 200 ms intervals (5 Hz), Figure 1). Two patterns 
of TBS stimulation were applied on consecutive days: intermittent 
theta burst stimulation (iTBS), shown to cause facilitation of the 
post-stimulation  MEP,  and  continuous  theta  burst  stimulation 
(cTBS), shown to cause suppression of the post-stimulation MEP 
(Huang et al., 2005). These sessions were counterbalanced such that 
cTBS was sometimes applied on day 1 and iTBS on day 2, while other 
times iTBS was applied on day 1 and cTBS on day 2. In the iTBS 
paradigm participants received a 2-s train of TBS repeated every 10-s 
for a total of 190 s (600 pulses), while in the cTBS paradigm they 
received a 47-s train of uninterrupted TBS (600 pulses).
To establish a baseline prior to TBS, three batches of 10 MEPs 
were recorded and measured in response to stimulation at a rate 
of approximately 0.1 Hz (a random jitter of ±1 s was introduced 
StiMulation and recording
For both the paired pulse and TBS sessions TMS induced motor-
evoked potentials (MEPs) were recorded with Ag–AgCl EMG sur-
face electrodes placed over the right first dorsal interosseus (FDI) 
muscle of the participant’s right hand. Raw signals were amplified 
and band-pass-filtered between 20 and 2000 Hz. EMG signals were 
digitized and sampled at a rate of 5000 Hz. TMS was delivered using 
a hand-held figure-eight coil attached to the Nexstim stimulator 
(for paired pulse paradigms, Nexstim Ltd, Helsinki, Finland)) and 
a Magstim Super Rapid stimulator (for TBS paradigms, Magstim 
Company Ltd, Spring Gardens, Wales, UK). The coil was placed 
tangentially to the scalp with the handle pointing posteriorly for 
all stimulation.
All stimulation was given over the hand area of the left motor 
cortex and individually localized for each participant based on 
the optimal position for eliciting MEPs in the right FDI. Cortico-
spinal  excitability  was  assessed  by  measuring  peak-to-peak 
amplitude of MEPs in the contralateral FDI muscle in response 
to TMS pulses.
Resting motor threshold (RMT) was determined as the mini-
mum single pulse intensity required to produce an MEP of greater 
than 50 μV on more than 5 out of 10 consecutive trials from the 
contralateral FDI muscle while the subject was at rest. Active motor 
threshold (AMT) was determined as the minimum single pulse 
intensity required to produce an MEP of greater than 200 μV on 
more than 5 out of 10 consecutive trials from the contralateral FDI 
muscle while the subject contracted the muscle at approximately 
20% of the maximal voluntary contraction.
In order to precisely target the stimulation site and keep the 
brain target constant throughout the paired pulse session, we 
used the Nexstim frameless stereotaxic system. (Nexstim Ltd, 
Helsinki, Finland). For the TBS sessions, we used a Brainsight 
frameless stereotactic system (Brainsight, Rogue Inc, Montreal, 
Canada). Both systems allow for online synchronization of a spe-
cific targeted brain region on an MRI with the online position 
of the subject and coil at a given moment and achieve a spatial 
resolution in the order of a fraction of a millimeter. In both cases 
the location of stimulation was kept constant through online 
feedback throughout the experimental session. These systems 
ensure that the exact same brain region is targeted on each trial 
and eliminate variability in the response as a result of changes 
in coil position.
Figure 2 | Schematic summary of the TBS experimental design. 
Cortico-spinal excitability was assessed using single pulse TMS. TBS was 
applied either as cTBS or iTBS to assess LTD- and LTP-like plasticity 
respectively. This procedure was then repeated 24 h later. The difference 
between the MEPs at baseline and following TBS can be used as an index of 
plasticity (LTD- or LTP-like depending on whether c or iTBS was applied) while 
the plasticity measure on day 1 compared to day 2 provides an index 
of metaplasticity.Frontiers in Synaptic Neuroscience  www.frontiersin.org  June 2010  | Volume 2  | Article 26  |  5
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in the   neurotypical   controls. On the other hand, findings in the 
ASD participants revealed a   heterogeneity in the sample, with 
one individual showing an enhancement during the SICI para-
digm and a different individual showing enhancement during 
the LICI paradigm.
cortical plaSticity and MetaplaSticity
The neurotypical individuals showed the expected suppression to 
cTBS and enhancement to iTBS on day 1, lasting approximately 
30 min (replicating previous reports, Huang et al., 2005). They 
also  showed  no  effect  of  the  previous  day’s  stimulation  when 
given the opposite paradigm on day 2, indicating that metaplas-
ticity mechanisms had been restored to baseline levels by 24 h (see 
Figure 4A).
The FXS participants, on day 1, showed no discernable response 
to the cTBS paradigm while showing an enhanced duration of 
response to the iTBS paradigm. The lack of response to cTBS was 
also present on day 2 when the participants had received iTBS on 
day 1. The enhanced response to iTBS that was present on day 1, 
however, was completely absent on day 2 when the participants had 
received cTBS on day 1, indicating an enhancement in metaplastic-
ity (see Figure 4B).
In the ASD sample, we replicated our previous finding of 
hyperplasticity in both the cTBS and iTBS paradigms on day 1. 
However, the response was strongly attenuated on day 2 in both 
paradigms when the opposite paradigm was applied on day 1, 
indicating an enhancement in both plasticity and metaplasticity 
in these individuals (see Figure 4C).
to avoid any train effects). Following TBS, batches of MEPs to 10 
single pulses also at a rate of approximately 0.1 Hz were measured 
at 5, 10, 20, 30, 40, 50, 60, 75, 90, 105, and 120 min following TBS, 
to track changes in amplitude over time. MEP amplitude at a given 
time point was defined as the mean amplitude of the 10 MEPs to 
single TMS pulses recorded in a given 2 min time window.
As an index of the duration of the TBS-induced modulation of 
cortical response (index of cortical plasticity), we defined for each 
participant the time point at which the average MEP amplitude fell 
within the 95% confidence interval of the baseline amplitude and 
did not return to outside that interval on subsequent time point 
measures. MEP amplitudes were standardized forming a ratio of 
MEP amplitudes following TBS relative to average baseline MEP 
amplitude for each individual. Metaplasticity was indexed as the 
difference in response to cTBS or iTBS on the second day as com-
pared to the first day.
reSultS
intracortical inhibition
All participants tolerated the TMS without any side-effects or 
complications. Figure 3 shows the average response to SICI and 
LICI for all individuals. All neurotypical control participants 
showed the expected suppression to both SICI and LICI. In both 
individuals with FXS SICI shows an approximately 63% sup-
pression from baseline, and matches the findings in neurotypical 
controls. Both FXS individuals also show a large degree (92%) 
reduction in the MEP amplitude to the second stimuli in the 
LICI paired pulse paradigm. Again these findings match those 
Figure 3 | Baseline responses to SiCi and LiCi paradigms. Bars indicate 
the average degree of suppression of the MEP as compared to baseline 
single pulse measures. Blue bars represent patients with FXS; red bars, 
participants with ASD; and yellow bars, healthy control participants. A value of 
less than one indicates suppression while a value of greater than one 
indicates enhancement.Frontiers in Synaptic Neuroscience  www.frontiersin.org  June 2010  | Volume 2  | Article 26  |  6
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On the other hand the normal SICI and LICI findings are 
  surprising. SICI and LICI are both measures of intracortical inhi-
bition thought to primarily reveal GABAergic mechanisms. Animal 
models of FXS demonstrate a cortical GABAergic dysfunction and 
thus our findings in humans are unexpected. Of course, it is pos-
sible that the assumption that SICI and LICI reveal GABAergic 
activity may be overly simplistic and incorrect. SICI is a complex 
phenomenon and recent studies have revealed different mecha-
nisms involved including excitation at certain ISIs and CSs. To 
measure pure GABAergic inhibitory system, ISI between 3–5 ms 
should be used so that SICI will not be contaminated and does not 
overlap with ICF (Hanajima et al., 2003; Vucic et al., 2009). Thus, 
our choice of ISI 3 ms was proper, as in earlier studies (Boroojerdi 
et al., 2000; Hammond et al., 2004). Some studies have proposed 
that ISIs between 2.1 and 2.6 ms to be most effective (Fisher et al., 
2002; Ilic et al., 2002; Orth et al., 2003; Roshan et al., 2003; Vucic 
et al., 2009), but these ISIs are in the range of concurrent facilitation 
(Ziemann et al., 1998). All of these ISIs are based on a neurotypi-
cal brain, thus it is possible that in an individual with FXS, these 
ISIs are not appropriate to evaluate purely GABAergic function-
ing. Furthermore, we have only studied two FXS patients thus far 
here, making these findings very preliminary. The results warrant 
diScuSSion
Our results demonstrate the utility of non-invasively assess-
ing intracortical inhibition and cortical plasticity in vivo in 
patients with neurodevelopmental disorders. In doing so, we 
have introduced a paradigm capable of translating the find-
ings from animal models of these disorders that can be applied 
across a wide range of ages and is not subject to participant’s 
performance or behavioral variability. Overall, our findings were 
consistent with animal models showing abnormalities in plas-
ticity and metaplasticity in both the FXS and ASD groups. The 
intracortical inhibition measures reveal heterogeneity in ASD, 
as might be expected based on the behavioral heterogeneity of 
the population.
In both FXs participants the lack of response to the cTBS, 
enhanced response to the iTBS and complete blocking of the iTBS 
response on day 2 are indicative of abnormalities in both plasticity 
and metaplasticity. Larger scale studies involving more participants 
as well as both males and females are necessary to further elucidate 
the extent of this apparent dysfunction. However, these results are 
certainly consistent with findings in animal models. The animal 
models predict abnormalities in both LTP and LTD based on over-
activity of the mGLUR5 receptor.
Figure 4 | Baseline corrected MeP amplitude following cTBS (in red) and iTBS (in blue) on day 1 and day 2 for the control group (A), FXS group (B), and 
ASD group (C). Values are represented as proportion of baseline amplitude with a line at 1.0 (representing baseline amplitude).Frontiers in Synaptic Neuroscience  www.frontiersin.org  June 2010  | Volume 2  | Article 26  |  7
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